Treatment of gastroesophageal reflux disease in 12-16 year old patients with rabeprazole
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions
- Sponsors Eisai Inc
- 03 Oct 2008 Results were reported at the 73rd Annual Scientific Meeting of the American College of Gastroenterology in October 2008.
- 24 Jun 2008 Status changed from in progress to completed, according to clinicaltrials.gov.
- 27 Nov 2005 New trial record.